Abstract
Chronic liver disease is a common problem in the practice of medicine. In this country, the majority of patients with this clinical illness are imbibers of the two-carbon fragment (ethanol) or have suffered the chronic consequences of hepatotropic viruses. There are, nonetheless, a smaller group of patients with chronic liver disease due to more unusual, yet treatable, causes. It is these patients who present particularly perplexing diagnostic challenges. The following Ohio State University Hospital case illustrates the difficulties and oversights that may occur with such patients.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Wilson BAK. Progressive lenticular degeneration: a familial nervous disease associated with cirrhosis of the liver. Brain. 1912;34:295–509.
Strickland GT, Lew ML. Wilson’s disease: clinical and laboratory manifestations in 40 patients. Medicine. 1975;54:113–37.
Winge DR. Normal physiology of copper metabolism. Seminars in Liver Disease. 1984; 4:239–50.
Brewer GJ, Hill GM, Prasad AS, Cossack ZT, et al. Oral zinc therapy for Wilson’s disease. Ann Intern Med. 1983;99:314–20.
Gibbs K, Walshe JM. Biliary excretion of copper in Wilson’s disease. Lancet. 1980;2:538–9.
Walshe JM. Copper: its role in the pathogenesis of liver disease. Seminars in Liver Disease. 1984;4:252–63.
Dobyns W, Goldstein NP, Gordon H. Clinical spectrum of Wilson’s disease. Mayo Clin Proc. 1979;54:35–42.
Sternlieb I. Copper and the liver. Gastroenterology. 1980;78:1615–28.
Roche-Suot J, Benhaman IP. Acute intravascular hemolysis and acute liver failure associated as a first manifestation of Wilson’s disease. Ann Int Med. 1977;86:301–3.
Scott I, Gallan JL, Samourean S, Sherlock S. Wilson’s disease presenting as chronic active hepatitis. Gastroenterology. 1978;74:645–51.
Wiekers DO, Hallenhurst RW, Goldstein NP. The ophthalmologic manifestations of Wilson’s disease. Mayo Clin Proc. 1977;52:409–16.
Sternlieb I, Scheinberg IM. Prevention of Wilson’s disease in asymptomatic patients. N Engl J Med. 1968;278:352–9.
Frommer D, Morris J, Sherlock S, Abrams J, et al. Kayser-Fleischer-like rings in patients without Wilson’s disease. Gastroenterology. 1977;73:1331–35.
Sternlieb I. Diagnosis of Wilson’s disease. Gastroenterology. 1978;74:787–93.
Vierling JM, Shrager R, Rumble WF, Aamedt R, et al. Incorporation of radiocopper into ceruloplasmin in normal subjects and in patients with primary biliary cirrhosis and Wilson’s disease. Gastroenterology. 1978;74:652–60.
Sternlieb I, Scheinberg IM. The role of radiocopper in the diagnosis of Wilson’s disease. Gastroenterology. 1979;77:13842.
Cartwright GE. Treatment of Wilson’s disease. N Engl J Med. 1978;298:1347–50.
Gibbs K, Walshe JM. Penillcillamine and pyridoxine requirements in man. Lancet. 1966; 1:175–9.
Walshe JM. Treatment of Wilson’s disease with trientine dihydrochloride. Lancet. 1982;1:643–7.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1988 Plenum Publishing Corporation
About this chapter
Cite this chapter
Thomas, F.B. (1988). Chronic Liver Disease and Neurologic Abnormalities. In: Bowen, J., Mazzaferri, E.L. (eds) Contemporary Internal Medicine. Contemporary Internal Medicine, vol 1. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-6713-4_1
Download citation
DOI: https://doi.org/10.1007/978-1-4615-6713-4_1
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4615-6715-8
Online ISBN: 978-1-4615-6713-4
eBook Packages: Springer Book Archive